- News Home
5 December 2013 11:26 am ,
Vol. 342 ,
An animal rights group known as the Nonhuman Rights Project filed lawsuits in three New York courts this week in an...
Researchers have been hot on the trail of the elusive Denisovans, a type of ancient human known only by their DNA and...
Thousands of scientists in the Russian Academy of Sciences (RAS) are about to lose their jobs as a result of the...
Dyslexia, a learning disability that hinders reading, hasn't been associated with deficits in vision, hearing, or...
Exotic, elusive, and dangerous, snakes have fascinated humankind for millennia. They can be hard to find, yet their...
Researchers have sequenced and analyzed the first two snake genomes, which represent two evolutionary extremes. The...
Snake venoms are remarkably complex mixtures that can stun or kill prey within minutes. But more and more researchers...
At age 30, Dutch biologist Freek Vonk has built up a respectable career as a snake scientist. But in his home country,...
- 5 December 2013 11:26 am , Vol. 342 , #6163
- About Us
Live Chat: How Close Are We to Birth Control for Men?
12 December 2012 9:05 am
See below for the chat box. Join us each Thursday at 3 p.m. EDT for a live conversation with leading scientists and expert reporters.
After decades of promising starts and dead ends, there's still no male equivalent of the female birth control pill. It's just not that easy to make an effective, safe, cheap, targeted, well-tolerated, bioavailable, easy-to-manufacture, side-effect-free, and (whew) completely reversible drug to block the production of sperm cells. In the past few years, though, biologists have opened up some new genetic and molecular leads for disrupting spermatogenesis, and there's optimism among reproductive scientists again. How close are we to the male pill this time? What pathways look promising? And will men really take it?
Join us for a live chat at 3 p.m. EST on Thursday, 13 December, on this page. You can leave your questions in the comment box below before the chat starts. The full text of the chat will be archived on this page.
Save to my calendar
You might also like:
Diana Blithe is the Program Director for the Contraceptive Development Research Centers Program and the Male Contraceptive Development Program at the National Institute of Child Health and Human Development. She also serves as the Co-Director of the Contraceptive Clinical Trials Network, overseeing clinical trials to evaluate the safety and efficacy of new contraceptive agents for men and women.
John Kenneth Amory
John Kenneth Amory is a Professor of Medicine and Section Head, University of Washington Section of General Internal Medicine. His research interests include the development of novel forms of male contraception and oral androgen therapy and new approaches to the treatment of men with infertility.
Sam Kean spent years collecting mercury from broken thermometers as a kid, and now he’s a writer in Washington, D.C.